Pharma development company forges partnership to offer drug delivery solutions
Nottingham-based R5 Pharmaceuticals has teamed up with Upperton, a privately-owned supplier of novel particles, to provide a one-stop service for drug delivery solutions.R5 Pharmaceuticals now offers spray-drying research, development, GMP and clinical manufacture under one roof.
Nottingham-based R5 Pharmaceuticals has teamed up with Upperton, a privately-owned supplier of novel particles, to provide a one-stop service for drug delivery solutions.R5 Pharmaceuticals now offers spray-drying research, development, GMP and clinical manufacture under one roof.
R5 Pharmaceuticals now offers spray-drying research, development, GMP and clinical manufacture under one roof.
The services mean that customers can assess the potential of spray drying for products without the expense of investing in equipment and allows the analysis of poorly soluble compounds and respiratory products.
Upperton ceo Richard Johnson, said: "Our expertise is highly specialised and the fit with R5 Pharmaceuticals was obvious. We are looking forward to working with them, as they advise and implement the development of even the most challenging molecules to meet their clients" needs."
R5 Pharmaceuticals ceo Paul Titley, said: "Increasingly, customers are looking for insight and expertise, but also flexibility and choice in developing the best formulations to bring a new product to market. R5 has combined industry expertise of well over 100 years, together with the most up to date facilities and the recently approved CRF."